Figure 1: Changes in HbA1c, GA and the GA/HbA1c ratio with sitagliptin.
Sitagliptin 50 mg/day was administered for 24 weeks to 69 patients with type 2 diabetes mellitus with stable glycemic control. Changes in HbA1c, GA and the GA/HbA1c ratio are shown.
*: P<0.001, **: P<0.0001 vs. 0 week